A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

Completed · Phase 2

Conditions studied: Renal Anemia

In brief

The purpose of this study is to test the safety and efficacy of FG-2216 in the treatment of patients with renal anemia who are not receiving erythropoietin and who are not on dialysis.

Key facts

Study ID

NCT00456053

Run by

Kyntra Bio

People needed

145

Starts

2005-12-01

Expected to finish

2007-07-01

Last updated by the study team

2007-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage 3 or 4 chronic kidney disease
• appropriate hemoglobin levels

You may not qualify if…

• Neovascular age related macular degeneration requiring treatment
• Macular edema or proliferative retinopathy in diabetic subjects, requiring treatment
• Any history of malignancy
• Therapy with recombinant erythropoietin or red blood cell transfusion within 4 weeks
• Renal Transplant

Where it is running

• Research Site — Orangeburg, South Carolina, United States
• Research Site — Houston, Texas, United States
• Research Site — San Antonio, Texas, United States
• Research Site — Chesapeake, Virginia, United States
• Research Site — Fairfax, Virginia, United States
• Research Site — Tucson, Arizona, United States
• Research Site — Little Rock, Arkansas, United States
• 3 Research Sites — Los Angeles, California, United States
• Research Site — Oakland, California, United States
• Research Site — San Diego, California, United States
• Research Site — Santa Clara, California, United States
• Research Site — Lauderdale Lakes, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Pembroke Pines, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — South Holland, Illinois, United States
• Research Site — Shreveport, Louisiana, United States
• Research Site — Springfield, Massachusetts, United States
• Research Site — Kalamazoo, Michigan, United States
• Research Site — Pontiac, Michigan, United States
• Research Site — Flushing, New York, United States
• Research Site — Cincinnati, Ohio, United States
• Research Site — Columbus, Ohio, United States
• Research Site — Portland, Oregon, United States
• Research Site — Allentown, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.